Anzeige
Mehr »
Login
Samstag, 15.08.2020 Börsentäglich über 12.000 News von 645 internationalen Medien
US-Goldaktie mit SENSATION: Übernahme perfekt und Spitzen-Manager von Barrick
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YHA5 ISIN: US23283M1018 Ticker-Symbol: 296 
Stuttgart
14.08.20
21:40 Uhr
3,200 Euro
-0,300
-8,57 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CYTODYN INC Chart 1 Jahr
5-Tage-Chart
CYTODYN INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,0603,30012:37

Aktuelle News zur CYTODYN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCytoDyn Reports Top-Line Data From Phase II Coronavirus Study34
Di NA Proactive news snapshot: Media Central Corporation, DGTL Holdings, Binovi Technologies, Innocan Pharma, Agile Therapeutics, CytoDyn ... UPDATE108
DiCytoDyn's leronlimab delivers health improvements for coronavirus patients in Phase 2 trial29
CYTODYN Aktie jetzt für 0€ handeln
DiCytoDyn announces "positive" results from mid-stage COVID-19 study35
DiCytoDyn Inc.: CytoDyn Announces Clinically Significant Top-line Results from its Phase 2 Trial in Mild-to-Moderate COVID-19 Patients16
07.08.NA Proactive news snapshot: Co-Diagnostics, Blackrock Gold Corp, First Mining Gold, Silvercorp Metals, CytoDyn, Nomad Royalty, Co-Diagnostics - UPDATE46
07.08.NA Proactive news snapshot: Silvercorp Metals, CytoDyn, Nomad Royalty, Co-Diagnostics ...13
07.08.CytoDyn seeks UK approval for its flagship drug leronlimab for HIV and coronavirus30
07.08.CytoDyn Inc.: CytoDyn Seeks UK Approval of Leronlimab for HIV and COVID-1928
04.08.NA Proactive news snapshot: CleanSpark, PreveCeutical Medical, Ximen Mining, BioLargo, CytoDyn, Biome Grow UPDATE …23
04.08.CytoDyn says that independent safety review of Phase 3 leronlimab trials found no concerns30
03.08.CytoDyn (CYDY) to Report Q4 Earnings: What's in the Offing?37
31.07.CytoDyn Inc. - 8-K, Current Report35
30.07.CytoDyn Inc lands $28.5M convertible note financing to fund leronlimab advancement31
30.07.CytoDyn Inc.: CytoDyn Completes Non-dilutive $28.5 Million Convertible Note Financing with Conversion Rate at $10.00 Per Share without Warrants43
29.07.CytoDyn's COVID-19 Trial Tribulations59
28.07.Moderna, Pfizer/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.302.497NEW YORK CITY (dpa-AFX) - Today's Daily Dose brings you news about Moderna moving its COVID-19 vaccine candidate into phase III testing, Pfizer/BioNTech selecting BNT162b2 vaccine candidate...
► Artikel lesen
27.07.CytoDyn to hold conference call to update on COVID-19 trials39
27.07.Interpretation Of Cytodyn's Mild-To-Moderate Covid-19 Results42
24.07.CytoDyn Inc. - 8-K, Current Report26
Seite:  Weiter >>
276 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,16